BitNile Holdings Sees FY2022 Sales $155.000M

BitNile Holdings (AMEX:NILE) sees FY2022 sales of $155.000 million.

byBenzinga Newsdesk

February 7, 2022

1 minute read

BitNile Holdings (AMEX:NILE) sees FY2022 sales of $155.000 million.

Biotech Company Pioneers Trademark Of MDMA Value Chain: Check Out The 2 Formats Available

By Lara Goldstein

Today, 5:50 AM

Pharmala Biotech Holdings Inc. (CSE: MDMA), a company focused on research, development and manufacturing of MDMA and similar class molecules, has registered a trademark for its clinical-grade, Good Manufacturing Practice MDMA product, to be available as “Laneo MDMA.”

CSE:MDMA

FDA
News

AstraZeneca’s Imfinzi (Durvalumab) In Combination With Imjudo (Tremelimumab) Plus Platinum-based Chemotherapy Has Been Approved By The Us Fda For The Treatment Of Adult Patients With Stage Iv (Metastatic) Non-small Cell Lung Cancer

By Charles Gross

Today, 5:50 AM

AstraZeneca's Imfinzi (durvalumab) in combination with Imjudo (tremelimumab) plus platinum-based chemotherapy has been approved in the US for the treatment of adult patients with Stage IV (metastatic) non-small cell lung cancer (NSCLC).

AZN